- In January 2025, Eli Health, a Canadian health-tech company, announced the launch of the Hormometer, an at-home saliva-based hormone testing device, at CES 2025. The Hormometer uses a smartphone camera and saliva samples to analyze hormones such as cortisol and progesterone, helping users monitor stress, sleep, and fertility. Priced at approximately USD 8 per test, the system is currently in beta rollout across the U.S. and Canada, emphasizing accessibility and convenience in personal health monitoring
- In January 2025, Nagpur-based startup ErlySign developed a 15-minute saliva test for early detection of oral precancerous conditions, showcasing 98.04% sensitivity and 100% specificity. The innovation received Rs 16 crore in pre-Series A funding and is currently undergoing regulatory approval, with full-scale commercialization expected by Q2 2026. The test aims to provide early, affordable screening in both clinical and rural settings, addressing oral cancer’s rising incidence in India
- In March 2024, Spectrum Solutions released the SimplyPERIO Saliva Test, powered by SimplyTest®, a new saliva diagnostic innovation that tests for periodontal bacteria, caries, fungal, and viral targets from a single sample. The test provides real-time clinical data on oral health, offering patients and providers a pain-free, easy-to-use method to detect gum disease and its link to systemic health issues. SimplyPERIO features a proprietary molecular technology and a patented blue buffer solution, ensuring room temperature stability without special storage or shipping requirements
- In January 2021, Vatic launched the KnowNow COVID-19 saliva test, a rapid 15-minute lateral flow test designed to identify current COVID-19 infections and determine who is infectious. Unlike other tests, it uses saliva collected from inside the cheek and under the tongue, detecting the spike protein on the virus’s surface by mimicking human cell properties. Paired with an app, the test provides documented proof of the result and infectiousness status. The test is CE Marked and aims to be deployed for workplace, travel, and event screenings, with potential for future self-testing
